Original articleInfluence of histology on the effectiveness of adjuvant chemotherapy in patients with hormone receptor positive invasive breast cancer
Under a Creative Commons license
open access
Highlights
► Invasive lobular breast cancer (ILC) is less responsive to neoadjuvant chemotherapy than ductal cancer (IDC). ► Patients with ILC also seem to benefit less from adjuvant chemotherapy than patients with IDC. ► Further research, based on randomized data or larger patient series, is urgently needed.
Keywords
Breast carcinoma
Invasive lobular carcinoma
Invasive ductal carcinoma
Hormonal therapy
Adjuvant chemotherapy
Survival
Cited by (0)
Copyright © 2011 Elsevier Ltd. All rights reserved.